Latest Abattis Bioceuticals (ATTBF) Headlines
Post# of 33
Posted On: 03/08/2014 11:29:14 PM
Latest Abattis Bioceuticals (ATTBF) Headlines
Abattis Issued Amendment to March 6, 2014 News Release - Abattis Ventures into the Washington State Legal Marijuana Market
ACCESSWIRE - Fri Mar 07, 9:32PM CST
Vancouver, BC / ACCESSWIRE / March 7, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CSE: ATT), wishes to amend the March 6th news release as follows:
Abattis Ventures Into The Washington State Legal Marijuana Market
ACCESSWIRE - Fri Mar 07, 7:42AM CST
Vancouver, BC / ACCESSWIRE / March 7, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CSE: ATT), wishes to announce that it has entered into Consulting Agreements with the principals from Phytalytics LLC, (D.B.A. PhytoLabs.com) of Kenmore, Washington USA whereby the consultants will make application to WSLCB (Washington State Liquor Control Board) for an analytics laboratory testing license. Phytalytics will provide government mandated testing of cannabis and all other cannabis related derivatives under State Initiative 502 ("SI502").
Abattis Announces Grant Of Options
ACCESSWIRE - Wed Mar 05, 6:41PM CST
Vancouver, BC / ACCESSWIRE / March 5, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CSE: ATT), wishes to announce that it has granted incentive stock options to a consultant of the Company to purchase up to 121,000 common shares of the Company. The options are exercisable on or before March 5, 2019, at an exercise price of $0.64 per share.
Abattis Announces Private Placement
ACCESSWIRE - Tue Mar 04, 8:46PM CST
Vancouver, BC / ACCESSWIRE / March 4, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CSE: ATT), announces a proposed private placement of up to $2,000,000.
Abattis Announces Amendment To Grant Of Options
ACCESSWIRE - Tue Mar 04, 7:48PM CST
Vancouver, BC / ACCESSWIRE / March 4, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CSE: ATT), announces the grant of 440,000 stock options to a consultant of the Company, exercisable at $0.45 per share for 5 years.
Abattis Signs LOI to Acquire Organic & Hydroponic Fertilizer Formulas
ACCESSWIRE - Thu Feb 27, 8:19PM CST
VANCOUVER, BC / February 27, 2014 / ACCESSWIRE / Abattis Bioceuticals Corp. ("Abattis" or the "Company") (CSE:ATT) (OTC: ATTBF), is pleased to announce that it has signed a letter of intent with the beneficial shareholder of Green-Gro Garden Products Ltd. ("Green-Gro") whereby the Company, through its wholly owned subsidiary, Biocube Green Grow Systems Corp., has agreed to acquire all of the organic and hydroponic fertilizer formulas owned by Green-Gro in consideration for 300,000 common shares of Abattis.
Abattis Announces it has Received Deficiency List for its Controlled Substance License Application
ACCESSWIRE - Thu Feb 20, 3:19PM CST
Vancouver, BC - February 20, 2014 - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CNSX: FLU), Health Canada Office of Controlled Substance has issued the deficiency list for Abattis' subsidiary, Northern Vine Canada Inc. application to obtain a Controlled Substance License for handling, analytics and extraction of Marihuana.
Abattis Announces Change of Stock Symbol to "ATT"
ACCESSWIRE - Thu Feb 20, 2:38PM CST
Vancouver, BC - February 20, 2014 - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CSE: FLU) wishes to announce that effective as the opening of trading of the Canadian Securities Exchange on Friday, February 21, 2014, the Company's common shares will commence trading under the new stock symbol "ATT".
Abattis Acquires Exclusive World Wide Distribution Rights to New Innovative Product for its Controlled Cultivation Environments
ACCESSWIRE - Tue Feb 18, 7:58AM CST
Vancouver, BC - February 18, 2014 - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CSE: FLU), through its wholly owned subsidiary, Biocube Green Grow Systems Corp. announces the company has acquired the Exclusive World Wide Distribution Rights to Jiangsu Jiahui New Material Co Ltd's. innovative MgO (Magnesium Oxide) products for use in any building or facility designed to cultivate botanicals.
Abattis Closes $600,000 Private Placement
ACCESSWIRE - Fri Feb 14, 3:23PM CST
Vancouver, BC - February 14, 2014 - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CSE: FLU) is pleased to announce that further to its news release of January 16, 2014, it has now closed the non-brokered private placement of 12,000,000 units for gross proceeds of $600,000.
Canaccord Fumes Over Pot Deal
at The Street - Fri Feb 14, 10:39AM CST
The Toronto-based wealth management and securities company helped aspiring pot grower Enertopia raise over a million dollars but, upon being informed by TheStreet that it had been credited in a regulatory filing, Canaccord wasn't feeling the vibes.
Early Warning Report Issued Pursuant to National Instrument 62-103 in Respect of the Acquisition of Shares of Abattis Bioceuticals Corp.
ACCESSWIRE - Mon Feb 03, 7:12PM CST
In accordance with regulatory requirements, Mr. Michael Withrow, the President, CEO, and a director of Abattis Bioceuticals Corp. (CNSX: FLU) ("Abattis"), announces that he has recently acquired, directly or indirectly, 1,500,000 shares of Abattis as a result of a Shares for Debt Agreement.
Abattis Appoints Rene David as Chief Financial Officer And Chief Operating Officer
ACCESSWIRE - Tue Nov 19, 12:22PM CST
Vancouver, BC - November 19, 2013 - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CNSX: FLU), announces the appointment of Rene David as its Chief Financial Officer and Chief Operating Officer.
Shareholder Update - Year in Review
ACCESSWIRE-TNW - Wed Mar 13, 11:27AM CDT
Major Milestones Met
Abattis Provides $10,000 Sponsorship to the American Herbal Pharmacopoeia for Cannabis Monograph Project
PR Newswire - Tue Mar 12, 2:38PM CDT
Abattis Bioceuticals Corp (OTC PINK: ATTBF) (CNSX: FLU) today announced that it has provided $10,000 sponsorship for the cannabis (cannabis sp.) monograph and therapeutic compendium currently under development by the American Herbal Pharmacopoeia (AHP).
Abattis Terminates $600,000 Private Placement
CNW Group - Mon Mar 11, 1:31PM CDT
Abattis Bioceuticals Corp. ("Abattis" or the "Company") (CNSX: FLU) (OTC: ATTBF), announces that it will not be proceeding with its $600,000 non-brokered private placement as previously announced in its Press Release dated February 12, 2013 as it is canvassing other avenues of financing through strategic relationships to prevent any dilution for its shareholders.
Abattis Issued Amendment to March 6, 2014 News Release - Abattis Ventures into the Washington State Legal Marijuana Market
ACCESSWIRE - Fri Mar 07, 9:32PM CST
Vancouver, BC / ACCESSWIRE / March 7, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CSE: ATT), wishes to amend the March 6th news release as follows:
Abattis Ventures Into The Washington State Legal Marijuana Market
ACCESSWIRE - Fri Mar 07, 7:42AM CST
Vancouver, BC / ACCESSWIRE / March 7, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CSE: ATT), wishes to announce that it has entered into Consulting Agreements with the principals from Phytalytics LLC, (D.B.A. PhytoLabs.com) of Kenmore, Washington USA whereby the consultants will make application to WSLCB (Washington State Liquor Control Board) for an analytics laboratory testing license. Phytalytics will provide government mandated testing of cannabis and all other cannabis related derivatives under State Initiative 502 ("SI502").
Abattis Announces Grant Of Options
ACCESSWIRE - Wed Mar 05, 6:41PM CST
Vancouver, BC / ACCESSWIRE / March 5, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CSE: ATT), wishes to announce that it has granted incentive stock options to a consultant of the Company to purchase up to 121,000 common shares of the Company. The options are exercisable on or before March 5, 2019, at an exercise price of $0.64 per share.
Abattis Announces Private Placement
ACCESSWIRE - Tue Mar 04, 8:46PM CST
Vancouver, BC / ACCESSWIRE / March 4, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CSE: ATT), announces a proposed private placement of up to $2,000,000.
Abattis Announces Amendment To Grant Of Options
ACCESSWIRE - Tue Mar 04, 7:48PM CST
Vancouver, BC / ACCESSWIRE / March 4, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CSE: ATT), announces the grant of 440,000 stock options to a consultant of the Company, exercisable at $0.45 per share for 5 years.
Abattis Signs LOI to Acquire Organic & Hydroponic Fertilizer Formulas
ACCESSWIRE - Thu Feb 27, 8:19PM CST
VANCOUVER, BC / February 27, 2014 / ACCESSWIRE / Abattis Bioceuticals Corp. ("Abattis" or the "Company") (CSE:ATT) (OTC: ATTBF), is pleased to announce that it has signed a letter of intent with the beneficial shareholder of Green-Gro Garden Products Ltd. ("Green-Gro") whereby the Company, through its wholly owned subsidiary, Biocube Green Grow Systems Corp., has agreed to acquire all of the organic and hydroponic fertilizer formulas owned by Green-Gro in consideration for 300,000 common shares of Abattis.
Abattis Announces it has Received Deficiency List for its Controlled Substance License Application
ACCESSWIRE - Thu Feb 20, 3:19PM CST
Vancouver, BC - February 20, 2014 - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CNSX: FLU), Health Canada Office of Controlled Substance has issued the deficiency list for Abattis' subsidiary, Northern Vine Canada Inc. application to obtain a Controlled Substance License for handling, analytics and extraction of Marihuana.
Abattis Announces Change of Stock Symbol to "ATT"
ACCESSWIRE - Thu Feb 20, 2:38PM CST
Vancouver, BC - February 20, 2014 - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CSE: FLU) wishes to announce that effective as the opening of trading of the Canadian Securities Exchange on Friday, February 21, 2014, the Company's common shares will commence trading under the new stock symbol "ATT".
Abattis Acquires Exclusive World Wide Distribution Rights to New Innovative Product for its Controlled Cultivation Environments
ACCESSWIRE - Tue Feb 18, 7:58AM CST
Vancouver, BC - February 18, 2014 - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CSE: FLU), through its wholly owned subsidiary, Biocube Green Grow Systems Corp. announces the company has acquired the Exclusive World Wide Distribution Rights to Jiangsu Jiahui New Material Co Ltd's. innovative MgO (Magnesium Oxide) products for use in any building or facility designed to cultivate botanicals.
Abattis Closes $600,000 Private Placement
ACCESSWIRE - Fri Feb 14, 3:23PM CST
Vancouver, BC - February 14, 2014 - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CSE: FLU) is pleased to announce that further to its news release of January 16, 2014, it has now closed the non-brokered private placement of 12,000,000 units for gross proceeds of $600,000.
Canaccord Fumes Over Pot Deal
at The Street - Fri Feb 14, 10:39AM CST
The Toronto-based wealth management and securities company helped aspiring pot grower Enertopia raise over a million dollars but, upon being informed by TheStreet that it had been credited in a regulatory filing, Canaccord wasn't feeling the vibes.
Early Warning Report Issued Pursuant to National Instrument 62-103 in Respect of the Acquisition of Shares of Abattis Bioceuticals Corp.
ACCESSWIRE - Mon Feb 03, 7:12PM CST
In accordance with regulatory requirements, Mr. Michael Withrow, the President, CEO, and a director of Abattis Bioceuticals Corp. (CNSX: FLU) ("Abattis"), announces that he has recently acquired, directly or indirectly, 1,500,000 shares of Abattis as a result of a Shares for Debt Agreement.
Abattis Appoints Rene David as Chief Financial Officer And Chief Operating Officer
ACCESSWIRE - Tue Nov 19, 12:22PM CST
Vancouver, BC - November 19, 2013 - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CNSX: FLU), announces the appointment of Rene David as its Chief Financial Officer and Chief Operating Officer.
Shareholder Update - Year in Review
ACCESSWIRE-TNW - Wed Mar 13, 11:27AM CDT
Major Milestones Met
Abattis Provides $10,000 Sponsorship to the American Herbal Pharmacopoeia for Cannabis Monograph Project
PR Newswire - Tue Mar 12, 2:38PM CDT
Abattis Bioceuticals Corp (OTC PINK: ATTBF) (CNSX: FLU) today announced that it has provided $10,000 sponsorship for the cannabis (cannabis sp.) monograph and therapeutic compendium currently under development by the American Herbal Pharmacopoeia (AHP).
Abattis Terminates $600,000 Private Placement
CNW Group - Mon Mar 11, 1:31PM CDT
Abattis Bioceuticals Corp. ("Abattis" or the "Company") (CNSX: FLU) (OTC: ATTBF), announces that it will not be proceeding with its $600,000 non-brokered private placement as previously announced in its Press Release dated February 12, 2013 as it is canvassing other avenues of financing through strategic relationships to prevent any dilution for its shareholders.
(0)
(0)